DexCom Total Assets 2010-2024 | DXCM

DexCom total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • DexCom total assets for the quarter ending September 30, 2024 were $6.354B, a 3.67% decline year-over-year.
  • DexCom total assets for 2023 were $6.265B, a 16.19% increase from 2022.
  • DexCom total assets for 2022 were $5.392B, a 9.29% increase from 2021.
  • DexCom total assets for 2021 were $4.933B, a 14.98% increase from 2020.
DexCom Annual Total Assets
(Millions of US $)
2023 $6,265
2022 $5,392
2021 $4,933
2020 $4,291
2019 $2,395
2018 $1,916
2017 $904
2016 $403
2015 $292
2014 $185
2013 $123
2012 $106
2011 $121
2010 $77
2009 $47
DexCom Quarterly Total Assets
(Millions of US $)
2024-09-30 $6,354
2024-06-30 $6,799
2024-03-31 $6,482
2023-12-31 $6,265
2023-09-30 $6,596
2023-06-30 $6,821
2023-03-31 $5,516
2022-12-31 $5,392
2022-09-30 $4,899
2022-06-30 $5,217
2022-03-31 $5,057
2021-12-31 $4,933
2021-09-30 $4,776
2021-06-30 $4,504
2021-03-31 $4,390
2020-12-31 $4,291
2020-09-30 $3,833
2020-06-30 $3,522
2020-03-31 $2,448
2019-12-31 $2,395
2019-09-30 $2,186
2019-06-30 $2,066
2019-03-31 $1,974
2018-12-31 $1,916
2018-09-30 $1,114
2018-06-30 $1,008
2018-03-31 $897
2017-12-31 $904
2017-09-30 $843
2017-06-30 $796
2017-03-31 $467
2016-12-31 $403
2016-09-30 $362
2016-06-30 $333
2016-03-31 $299
2015-12-31 $292
2015-09-30 $257
2015-06-30 $218
2015-03-31 $189
2014-12-31 $185
2014-09-30 $159
2014-06-30 $140
2014-03-31 $125
2013-12-31 $123
2013-09-30 $110
2013-06-30 $102
2013-03-31 $99
2012-12-31 $106
2012-09-30 $103
2012-06-30 $111
2012-03-31 $118
2011-12-31 $121
2011-09-30 $129
2011-06-30 $136
2011-03-31 $67
2010-12-31 $77
2010-09-30 $54
2010-06-30 $61
2010-03-31 $68
2009-12-31 $47
2009-09-30 $54
2009-06-30 $65
2009-03-31 $78
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $28.447B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $196.322B 23.95
Intuitive Surgical (ISRG) United States $195.140B 102.02
Alcon (ALC) Switzerland $42.414B 28.38
Edwards Lifesciences (EW) United States $41.569B 26.40
IQVIA Holdings (IQV) United States $36.630B 20.18
IDEXX Laboratories (IDXX) United States $34.166B 40.24
Waters (WAT) United States $22.175B 32.79
STERIS (STE) Ireland $21.157B 24.36
SONOVA HOLDING (SONVY) Switzerland $20.795B 0.00
Hologic (HOLX) United States $18.343B 19.36
Fresenius Medical Care AG KGaA (FMS) Germany $13.004B 13.35
Sysmex ADR (SSMXY) Japan $12.946B 40.60
Globus Medical (GMED) United States $11.536B 29.21
Penumbra (PEN) United States $9.397B 92.05
Masimo (MASI) United States $9.260B 44.81
Teleflex (TFX) United States $8.904B 14.20
Glaukos (GKOS) United States $7.940B 0.00
PROCEPT BioRobotics (PRCT) United States $4.884B 0.00
Integer Holdings (ITGR) United States $4.632B 26.26
Veracyte (VCYT) United States $3.068B 92.07
Inari Medical (NARI) United States $2.907B 0.00
LivaNova (LIVN) United Kingdom $2.787B 16.09
TransMedics (TMDX) United States $2.552B 80.89
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.167B 17.66
Tandem Diabetes Care (TNDM) United States $2.024B 0.00
Integra LifeSciences Holdings (IART) United States $1.820B 9.51
RxSight (RXST) United States $1.807B 0.00
Alphatec Holdings (ATEC) United States $1.427B 0.00
Artivion (AORT) United States $1.185B 78.53
Pulse Biosciences (PLSE) United States $1.088B 0.00
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.855B 14.53
Paragon 28 (FNA) United States $0.841B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.723B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.638B 0.00
Mesa Laboratories (MLAB) United States $0.593B 13.97
AxoGen (AXGN) United States $0.587B 0.00
SiBone (SIBN) United States $0.527B 0.00
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.488B 0.00
Semler Scientific (SMLR) United States $0.462B 31.05
Tactile Systems Technology (TCMD) United States $0.428B 23.18
CVRx (CVRX) United States $0.360B 0.00
ClearPoint Neuro (CLPT) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.312B 0.00
NeuroPace (NPCE) United States $0.290B 0.00
AngioDynamics (ANGO) United States $0.278B 0.00
Inogen (INGN) United States $0.223B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
Accuray (ARAY) United States $0.194B 0.00
Nevro (NVRO) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.60
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Vicarious Surgical (RBOT) United States $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Neuronetics (STIM) United States $0.027B 0.00
NexGel (NXGL) United States $0.023B 0.00
Spectral AI (MDAI) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00